2021
DOI: 10.1002/adtp.202100210
|View full text |Cite
|
Sign up to set email alerts
|

Nanoarchitectonics with Two‐Dimensional Black Phosphorus and MnO2 for Synergistic Photodynamic‐/Radiotherapy Against Cancer through Enhanced Reactive Oxygen Species Activity

Abstract: Reactive oxygen species (ROS) can kill cancer cells in tumor therapy. However, the anticancer efficacy of ROS is generally suppressed by the reductive press in tumor microenvironment (TME). Herein, lysozyme (LZM) modified black phosphorous (BP) /manganese dioxide nanosheets (LZM@BP/MnO 2 NSs, LBM) as an effective and biocompatible nanodrug platform for synergistic photodynamic-/radio-therapy are prepared. The controllable preparation of negatively charged MnO 2 NSs is achieved through biomimetic mineralization… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 30 publications
(38 reference statements)
0
3
0
Order By: Relevance
“…Most importantly, the ability of LBM to amplify intracellular ROS generation assisted with the combination of PDT and radiotherapy and ultimately increased the efficacy of synergistic cancer therapy. 74 Yu et al prepared TME-regulated SiO 2 @MnO 2 NPs (called SM NPs) to increase the efficacy of radiotherapy combined with immunotherapy. In bilateral animal models, SM NPs increased the inhibitory effect of radiotherapy not only on the growth of primary tumors but also on the growth of distant untreated tumors.…”
Section: Mno 2 -Based Nanomaterials For Radiotherapymentioning
confidence: 99%
See 1 more Smart Citation
“…Most importantly, the ability of LBM to amplify intracellular ROS generation assisted with the combination of PDT and radiotherapy and ultimately increased the efficacy of synergistic cancer therapy. 74 Yu et al prepared TME-regulated SiO 2 @MnO 2 NPs (called SM NPs) to increase the efficacy of radiotherapy combined with immunotherapy. In bilateral animal models, SM NPs increased the inhibitory effect of radiotherapy not only on the growth of primary tumors but also on the growth of distant untreated tumors.…”
Section: Mno 2 -Based Nanomaterials For Radiotherapymentioning
confidence: 99%
“…In addition, LBM easily decomposed at the tumor site and exhibited high biocompatibility both in vitro and in vivo. Most importantly, the ability of LBM to amplify intracellular ROS generation assisted with the combination of PDT and radiotherapy and ultimately increased the efficacy of synergistic cancer therapy …”
Section: Application Of Mno2-based Nanomaterials For Tumor Therapymentioning
confidence: 99%
“…Considering the underlying interaction between nanozymes and the TME, some strategies of using enzymes as a therapeutic agent to alleviate tumor hypoxia have been proposed to improve the therapeutic effect. , Nanozymes, as the next-generation artificial enzymes, possess higher stability and durability in harsh environments, which afford preferable opportunities for antitumor therapy. Currently, the design of cascade nanozyme systems that integrate multifunctional enzyme activities has been proposed for the treatment of various diseases including cancer, inflammation, and wound healing. Jiang’s group developed iridium oxide nanoparticles with multifunctional enzyme activity that broke the chaos of tumors by cascade reactions . Wang et al fabricated an organic framework-based nanozyme as a glucose-triggered cascade catalyst against bacterial wound infection .…”
mentioning
confidence: 99%